WA

Healthcare · Pharmaceuticals

Wanbury Ltd (WANBURY)

₹179.37

Mkt cap
₹676 Cr
P/E ratio
12.10
P/B
3.92
Div yield
0.00%
ROE
68.40%
ROCE
30.70%
EPS (TTM)
₹14.82
Book value
₹46
52W range
162–359
Sector
Healthcare

Price history

Previous close

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research [1]

NSE WANBURYBSE 524212
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−50.02% from high
₹179
₹162+11.07% from low₹359
Current
₹179.37
Prev close
₹181.66
Day
−1.26%
Price performance
1D
−1.46%
1W
−7.47%
1M
−3.64%
3M
−33.33%
6M
−36.75%
1Y
−25.57%
YTD
−24.00%

Financials

Revenue, profit & margin
P/E ratio
12.1×
WANBURY is 64% below the sector median of 34.0×
WANBURY12.1×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales144146139131161133172163160162165166183
YoY Sales growth+17%+16%+5%-10%+12%-8%+23%+24%-1%+22%-4%+1%+14%
Expenses127124121120141120142139134136135149157
Operating Profit17211811201430242627301626
OPM %12%15%13%8%12%10%17%15%16%16%18%10%14%
Other Income1111212000-300
Interest887810109877886
Depreciation3333333444344
Profit before tax71081811914151615516
Tax %-2%-0%3%0%2%5%-6%1%-0%1%-43%29%24%
Net Profit71081812013151622312
EPS in Rs2.253.142.470.322.450.376.184.104.354.526.210.933.40
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.04% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '26◦4 Nov '26◦
Earnings day+3.32%−3.25%
+1 day−1.26%+3.45%
+5 days+6.00%+0.55%
+15 days−3.66%—
+30 days−11.46%—
FilingPDFPDF

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
42.98%Promoter
Promoters42.98%0.03
FIIs0.71%0.18
DIIs0.02%0.04
Public56.28%0.24
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Wanbury₹193.4612.076760.00%12−21.74%183+14.28%30.66%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings